Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Affective Symptoms in First-Episode Psychosis
NCT00511277Phase 4Completed
- Sponsor
- Institut für anwendungsorientierte Forschung und klinische Studien
- Start
- Aug 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quetiapine (extended-release tablet, brand name: Bipresso) in schizophrenia, sponsored by Institut für anwendungsorientierte Forschung und klinische Studien. Primary endpoint: Hamilton Depression Rating Scale at 6 months. Started Aug 2007; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00511277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511277.